# Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

> **NCT00296686** · PHASE4 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 31 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Tranylcypromine
- **DRUG:** Dextroamphetamine
- **DRUG:** Triiodothyronine

## Key facts

- **NCT ID:** NCT00296686
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-09
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Study is no longer funded.
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296686, "Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00296686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*